Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478036 · ClinicalTrials.gov registry record · NA
Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00478036 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 31 participants.
The verdict
NCT00478036, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The Investigators will compare, in a randomized, prospective, masked and controlled fashion the effect of a non-steroidal anti-inflammatory agent (Acular LS), a corticosteroid (Pred Forte) and a placebo (Refresh Tears) on patient discomfort, degree of intraocular pressure (IOP) lowering and degree of ocular inflammation following selective laser trabeculoplasty treatment for open angle glaucoma.
Interventions
- DRUG Pred Forte
- DRUG Acular LS
- OTHER Refresh Tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2007-05 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00478036
The ClinicalTrials.gov registry entry for NCT00478036 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pred Forte is the first listed.
NCT00478036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00478036 about?
NCT00478036 is a clinical study titled "Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells". The Investigators will compare, in a randomized, prospective, masked and controlled fashion the effect of a non-steroidal anti-inflammatory agent (Acular LS), a corticosteroid (Pred Forte) and a placebo (Refresh Tears) on patient discomfort, degree of intraocular pressure (IOP) lowering and degree o...
What is the current status of trial NCT00478036?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2007-05. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00478036?
The interventions under investigation include: Pred Forte (DRUG), Acular LS (DRUG), Refresh Tears (OTHER).
Who is sponsoring clinical trial NCT00478036?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.